Double-scattered proton-based stereotactic body radiotherapy for stage i lung cancer: A dosimetric comparison with photon-based stereotactic body radiotherapy

Radiotherapy and Oncology

Volumn 97, Issue 3, 2010, Pages 425-430

  Hoppe, Bradford S ^a,c   Huh, Soon ^a   Flampouri, Stella ^a   Nichols, Romaine C ^a   Oliver, Kenneth R ^b   Morris, Christopher G ^a   Mendenhall, Nancy P ^a   Li, Zuofeng ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b MAYO CLINIC   (United States)

^c NONE   (United States)

Author keywords

Dosimetry; Lung cancer; Proton therapy; Stereotactic body radiotherapy

Indexed keywords

ARTICLE; BRONCHUS; CANCER STAGING; CLINICAL ARTICLE; DOSIMETRY; EARLY CANCER; ESOPHAGUS; HEART; HUMAN; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT RESPONSE;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG; LUNG NEOPLASMS; PHOTONS; PROTONS; RADIOSURGERY; RADIOTHERAPY DOSAGE;

EID: 78651488982     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2010.09.006     Document Type: Article

References (33)

1. J.G. Armstrong Conformity index (CI) and radiation treatment of lung cancer: in regards to Chang et al. (Int J Radiat Oncol Biol Phys 2006;65:1087-1096) Int J Radiat Oncol Biol Phys 68 2007 1272
2. P. Baumann, J. Nyman, and I. Lax Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries Acta Oncol 45 2006 787 795
3. J.D. Bradley, I. El Naqa, R.E. Drzymala, M. Trovo, and G. Jones Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant Int J Radiat Oncol Biol Phys 2009
4. D.A. Bush, J.D. Slater, B.B. Shin, G. Cheek, D.W. Miller, and J.M. Slater Hypofractionated proton beam radiotherapy for stage I lung cancer Chest 126 2004 1198 1203
5. J.Y. Chang, X. Zhang, and X. Wang Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer Int J Radiat Oncol Biol Phys 65 2006 1087 1096
6. D. Coon, A.S. Gokhale, S.A. Burton, D.E. Heron, C. Ozhasoglu, and N. Christie Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning Clin Lung Cancer 9 2008 217 221
7. D.E. Dosoretz, D. Galmarini, and J.H. Rubenstein Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication Int J Radiat Oncol Biol Phys 27 1993 507 516
8. D.E. Dosoretz, M.J. Katin, and P.H. Blitzer Radiation therapy in the management of medically inoperable carcinoma of the lung: results and implications for future treatment strategies Int J Radiat Oncol Biol Phys 24 1992 3 9
9. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
10. D. Georg, M. Hillbrand, M. Stock, K. Dieckmann, and R. Potter Can protons improve SBRT for lung lesions? Dosimetric considerations Radiother Oncol 88 2008 368 375
11. K. Han, P. Cheung, P.S. Basran, I. Poon, L. Yeung, and F. Lochray A comparison of two immobilization systems for stereotactic body radiation therapy of lung tumors Radiother Oncol 95 2010 103 108
12. M. Hata, K. Tokuuye, and K. Kagei Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study Int J Radiat Oncol Biol Phys 68 2007 786 793
13. B.S. Hoppe, B. Laser, and A.V. Kowalski Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk? Int J Radiat Oncol Biol Phys 72 2008 1283 1286
14. H. Iwata, M. Murakami, and Y. Demizu High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer Cancer 116 2010 2476 2485
15. N. Kadoya, Y. Obata, and T. Kato Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer Int J Radiat Oncol Biol Phys 2010
16. Y. Kang, X. Zhang, and J.Y. Chang 4D Proton treatment planning strategy for mobile lung tumors Int J Radiat Oncol Biol Phys 67 2007 906 914
17. Q.T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
18. R. Liu, J.M. Buatti, T.L. Howes, J. Dill, J.M. Modrick, and S.L. Meeks Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions Int J Radiat Oncol Biol Phys 66 2006 906 912
19. O.K. Macdonald, J.J. Kruse, and J.M. Miller Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis Int J Radiat Oncol Biol Phys 75 2009 950 958
20. T. Miyamoto, M. Baba, and T. Sugane Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week J Thorac Oncol 2 2007 916 926
21. U. Mock, D. Georg, J. Bogner, T. Auberger, and R. Potter Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma Int J Radiat Oncol Biol Phys 58 2004 147 154
22. H. Nakayama, S. Sugahara, and M. Tokita Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the University of Tsukuba Int J Radiat Oncol Biol Phys 2010
23. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 2007 S94 100
24. N. Pettersson, J. Nyman, and K.A. Johansson Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis Radiother Oncol 91 2009 360 368
25. S.P. Register, X. Zhang, R. Mohan, and J.Y. Chang Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 2010
26. U. Ricardi, A.R. Filippi, and A. Guarneri Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy Acta Oncol 48 2009 571 577
27. C.F. Serago, A.F. Thornton, and M.M. Urie Comparison of proton and x-ray conformal dose distributions for radiosurgery applications Med Phys 22 1995 2111 2116
28. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
29. W.S. van de, R. Kreuger, S. Zenklusen, E. Hug, and A.J. Lomax Tumour tracking with scanned proton beams: assessing the accuracy and practicalities Phys Med Biol 54 2009 6549 6563
30. G.M. Videtic, K. Stephans, and C. Reddy Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control Int J Radiat Oncol Biol Phys 2009
31. D.C. Weber, A.W. Chan, and S. Lessell Visual outcome of accelerated fractionated radiation for advanced sinonasal malignancies employing photons/protons Radiother Oncol 81 2006 243 249
32. J. Welsh, J. Thomas, and D. Shah Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapy Int J Radiat Oncol Biol Phys 2010
33. F.B. Zimmermann, H. Geinitz, and S. Schill Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer Lung Cancer 48 2005 107 114